Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 37.64
- Piotroski Score 4.00
- Grade Buy
- Symbol (DYN)
- Company Dyne Therapeutics, Inc.
- Price $32.56
- Changes Percentage (-2.95%)
- Change -$0.99
- Day Low $32.39
- Day High $34.00
- Year High $47.45
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/27/2024
- Fiscal Year End N/A
- Average Stock Price Target $45.00
- High Stock Price Target $55.00
- Low Stock Price Target $18.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.98
- Trailing P/E Ratio -7.77
- Forward P/E Ratio -7.77
- P/E Growth -7.77
- Net Income $-235,937,000
Income Statement
Quarterly
Annual
Latest News of DYN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Inside Meghan Markle and Prince Harry's New Dynamic: 'A Twin-Track Approach Is Evolving,' Friend Says (Exclusive)
Erin Hill is the Senior Editor, Royals at PEOPLE, with experience reporting on Royals since 2015. Prince Harry and Meghan Markle have shifted focus post-royal life, with Harry dedicated to philanthrop...
By PEOPLE.com | 1 day ago -
AngioDynamics Inc (ANGO) Q1 2025 Earnings Call Transcript Highlights: A Promising Start with ...
The earnings call discussed positive feedback on the AlphaVac PE launch and strategies to penetrate the Auryon hospital market. The company aims for profitability through increased penetration. Manufa...
By Yahoo! Finance | 1 day ago -
Jordyn Blum 'Doesn't Trust' Dave Grohl After He Welcomed Baby Outside of Marriage: 'It's Been Rough' (Exclusive Source)
Jordyn Blum, wife of Dave Grohl, is focusing on her life and daughters after Grohl revealed a child outside their marriage. Blum is leaning on friends for support as she navigates through this challen...
By PEOPLE.com | 2 days ago